- All Journals
- Al-Qadisiyah University
- Basrah University
- Kirkuk University
- Mosul University
- The Iraqi Borad for Medical Specialization
- University of Anbar
- University of Technology
- Al Mustafa University
- Al-Zahraa University for Women
- Alnoor University
- Kunooz University
- Misan University
- Ninevah University
- Tikrit University
- University of Al-Hamdaniya
- University of Kerbala
Effect of Ginkgo biloba on lipid profile in hypertensive patients on Valsartan monotherapy | ||
| Annals of the College of Medicine, Mosul | ||
| Article 5, Volume 40, Issue 2, 2018, Pages 29-33 PDF (0 K) | ||
| DOI: 10.33899/mmed.2018.160002 | ||
| Authors | ||
| Safaa A. Al-Zakaria; Imad A-J Thanon; Luma M Saadallah | ||
| Abstract | ||
| Aim: The study was conducted to evaluate the effects of Ginkgo biloba as an add on therapy to Valsartan monotherapy in hypertensive patients on lipid profile. Patients and methods: The study was done in private clinics in Mosul City, during a period of sixth months from 15 October 2017 to 15 April 2018. The total number of patients enrolled in the study was 50 hypertensive patients using Valsartan monotherapy of both sexes. The patients were administered Ginkgo biloba 80 mg twice daily and followed for 2 months duration. Their lipid profile was determined at baseline level and after 2 months from administration of Ginkgo biloba. Results: Treatment with Ginkgo biloba showed a significant reduction in serum total cholesterol and triglycerides, while LDL, VLDL, HDL, and AI showed no significant changes. Conclusion: This study revealed that Ginkgo biloba could be regarded as a natural and relatively safe drug in reducing total cholesterol and triglycerides in hypertensive patients. . | ||
| Keywords | ||
| Hypertensive patients; Spectrophotometry; Valsartan monotherapy; oxidative coupling; Ginkgo biloba; Mesalazine; Lipid profile; histidine | ||
|
Statistics Article View: 739 PDF Download: 3,461 |
||